menopause and semaglutide Can Help with Weight Gain? – PlexusDx A New Match for Menopausal

What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months

For Wegovy (semaglutide), you'll typically increase your dose every four weeks until you reach the full maintenance dose of 2.4 mg

This is often the case with fad diet products

4 Who qualifies for treatment